- Antimicrobial Action– LL-37 is the only human cathelicidin peptide, widely studied for its broad-spectrum activity against bacteria, fungi, and some viruses by disrupting microbial membranes.
- Immune Modulation– Investigated for regulating innate immunity, balancing pro- and anti-inflammatory responses, and enhancing the activity of immune cells like macrophages and neutrophils.
- Wound Healing & Tissue Repair– Stimulates angiogenesis, fibroblast migration, and re-epithelialization, accelerating closure of chronic wounds and ulcers in preclinical research.
- Respiratory & Lung Research– Explored for protective effects in airway infections, asthma, COPD, and cystic fibrosis models.
- Anti-Cancer Potential– Early studies suggest LL-37 may influence tumor progression differently depending on tissue context, making it a focus in oncology research.
- Systemic Effects – Studied for roles in sepsis, autoimmune regulation, and tissue regeneration across multiple organ systems.
